CLINICAL TRIALS PROFILE FOR NOVOLOG FLEXPEN
✉ Email this page to a colleague
All Clinical Trials for NOVOLOG FLEXPEN
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00906529 ↗ | Aggressive Versus Conservative Blood Glucose Control in Hospitalized Type 2 Diabetic Patients Using Detemir and Aspart Insulin | Withdrawn | Novo Nordisk A/S | Phase 4 | 2009-05-01 | The purpose of this study is to determine whether aggressive (goal pre-prandial blood glucose <110 mg/dl) versus conservative (goal pre-prandial blood glucose <180mg/dl) diabetes treatment of type 2 diabetic patients on the general medical wards has any effect on hospital outcomes. |
NCT00906529 ↗ | Aggressive Versus Conservative Blood Glucose Control in Hospitalized Type 2 Diabetic Patients Using Detemir and Aspart Insulin | Withdrawn | University of Texas Southwestern Medical Center | Phase 4 | 2009-05-01 | The purpose of this study is to determine whether aggressive (goal pre-prandial blood glucose <110 mg/dl) versus conservative (goal pre-prandial blood glucose <180mg/dl) diabetes treatment of type 2 diabetic patients on the general medical wards has any effect on hospital outcomes. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for NOVOLOG FLEXPEN
Condition Name
Clinical Trial Locations for NOVOLOG FLEXPEN
Trials by Country
Clinical Trial Progress for NOVOLOG FLEXPEN
Clinical Trial Phase
Clinical Trial Sponsors for NOVOLOG FLEXPEN
Sponsor Name